Fabian Gerlinghaus, co-founder and CEO of Cellares, discusses their novel technology, the Cell Shuttle, a solution for scaling cell therapy manufacturing. The tech is capable of significantly increasing cell yields and cutting costs for pharmaceutical companies, positioning itself at the forefront of personalized medicine’s future.
Valley Man Who Sold Spying Malware, Pleads To Conspiracy
A man from Van Nuys has confessed to conspiring to sell malware, known as Hive RAT, that allowed buyers to illegally access computers, stealing personal
